A new study shows that the aromatase inhibitor letrozole can prevent late recurrence of breast cancer.

References and Resources
Goss P, et al. Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen. Journal of Clinical Oncology. 2008. 10:1200.

Sponsored by The Doctor’s Channel